ICB INTERNATIONAL
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
ICB INTERNATIONAL
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2008-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.icbii.com
Total Employee:
1+
Status:
Active
Contact:
8587552907
Email Addresses:
[email protected]
Total Funding:
895 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Official Site Inspections
http://www.icbii.com
- Host name: 107.223.169.192.host.secureserver.net
- IP address: 192.169.223.107
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ICB International"
About – ICBI - icbii.com
Sep 22, 2021 With her near three decades of experience as President and Executive Director of Parkinson’s Resource Organization, Ms. Rosen personally met the challenges of Parkinson’s …See details»
ICBI – OutSMARTing Barriers
OutSMARTing Barriers. ICBI’s game-changing SMART Molecule Technology Platform is capable of delivering therapeutic drugs across the blood-brain barrier and into the central nervous system to treat neurodegenerative disorders such …See details»
ICB International - Crunchbase Company Profile
Contact Email [email protected] Phone Number 8587552907 Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology …See details»
ICBI Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ICBI. Use the PitchBook Platform to explore the full profile.See details»
ICB International Company Profile | Management and Employees List
Www.icbii.com ICB International Profile and History Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a …See details»
ICB International, Inc. - Company Profile & Staff Directory
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to …See details»
Innovative California Biosciences International, Inc.
Nov 1, 2024 www.icbii.com. Holding Company | 2008 | California, United States | www.icbii.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The …See details»
ICB International, Inc. – San Diego Biotechnology Network
Jan 6, 2025 Organization Type. Privately Held. Size Range. 1-10. Geographical Area. Greater San Diego Area. Follow @ICBII. Advertisement. ADVERTISEMENT — Advertise With Biotech …See details»
Employment – ICBI - icbii.com
ICB International, Inc., (“ICBII”), La Jolla, California is dedicated to developing disease altering therapies for diseases of the central nervous system (CNS) to ameliorate the sufferings of …See details»
ICB International - Craft
ICB International (ICBI) is a company that provides disease altering therapies for afflictions of the central nervous system (CNS). Its SMART molecule technology platform enables the …See details»
ICB International - Overview, News & Similar companies - ZoomInfo
Aug 17, 2021 Innovative California Biosciences International, Inc., ("ICBII"), announced on April 15th the approval of its patent for Blood-Brain Barrier (BBB) Permeable Peptide Composition. …See details»
ICBII UPDATE ON THE ROAD TO THE CURE (May 2022)
Apr 28, 2022 ICB International, Inc., (“ICBII”), a La Jolla, CA, based biopharmaceutical company decided early on not to do what most of the pharmaceutical companies have been following for …See details»
ICBII Update on the Road to the Cure (February, 2022)
Jan 31, 2022 Please contact ICBI directly through their website ICBII.com or by phone 858-455-9880. IMAGINE the world without Parkinson’s, MSA, or Alzheimer’s disease. ... Parkinson's …See details»
ICBII UPDATE ON THE ROAD TO THE CURE - JANUARY 2023
Jan 1, 2023 The joy of being a part of these historical events can be had by helping ICBII find the funds to bring these trials to fruition through your investing, and by finding others with the …See details»
News – ICBI - icbii.com
Sep 22, 2021 La Jolla, California, USA, Innovative California Biosciences International, Inc., (“ICBII”), announced on December 21, 2018… admin December 18, 2018 ICBII Announces …See details»
ICB International, Inc. Launches Blood-Brain Barrier Crossing Smart ...
Jun 9, 2015 BEVERLY HILLS, CA / ACCESSWIRE / June 9, 2015 / ICB International Inc., ("ICBI or ICBII"), launches Blood-Brain Barrier crossing SMART Molecule platform technology and …See details»
Contact – ICBI - icbii.com
Come & Visit Us. 505 Coast Blvd South, #405 La Jolla, CA 92037, USA. Give Us A Call +1-858-455-9880See details»
Icb International, Inc. - Drug pipelines, Patents, Clinical trials ...
Abstract Background Alzheimer’s disease (AD), the most common cause of dementia, is a slowly progressing neurodegenerative disorder that has become an escalating global epidemic with …See details»
PRIVACY POLICY TEXT - Parkinson's Resource Organization
Apr 30, 2019 Using prior licensing deals as benchmarks, ICBII had quoted the licensing fees for its MSA and Parkinson’s drugs to a European pharma. The European company is now …See details»
Press Releases – ICBI - icbii.com
Dec 18, 2018 La Jolla, California, USA, Innovative California Biosciences International, Inc., (“ICBII”), announced on December 21, 2018… admin December 18, 2018 ICBII Announces …See details»